The current use of nanotechnology in the fight against antimicrobial resistance: promising approaches to global health challenge
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Advanced Nanomaterials in Catalysis · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Salam MA, Al-Amin MY, Salam MT, et al (2023) Antimicrobial resistance: a growing serious threat for global public health. In: Healthcare. MDPI, p 194610.20944/preprints202305.0555.v1 ↗
2. Walsh TR, Gales AC, Laxminarayan R, Dodd PC (2023) Antimicrobial resistance: addressing a global threat to humanity. PLoS Med 20:e100426410.1371/journal.pmed.1004264 ↗
3. Abushaheen MA, Fatani AJ, Alosaimi M et al (2020) Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 66:10097110.1016/j.disamonth.2020.100971 ↗
4. Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4:48210.3934/microbiol.2018.3.482 ↗
5. Mittal AK, Bhardwaj R, Mishra P, Rajput SK (2020) Antimicrobials misuse/overuse: adverse effect, mechanism, challenges and strategies to combat resistance. Open Biotechnol J 14:107–11210.2174/1874070702014010107 ↗
6. Endale H, Mathewos M, Abdeta D (2023) Potential causes of spread of antimicrobial resistance and preventive measures in one health perspective-a review. Infect Drug Resist 16:7515–754510.2147/IDR.S428837 ↗
7. Berkley JA (2019) Mass antibiotic distribution to reduce mortality among preschool children? Arch Dis Child 104:227–22810.1136/archdischild-2018-315451 ↗
8. Muteeb G, Rehman MT, Shahwan M, Aatif M (2023) Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals 16:161510.3390/ph16111615 ↗
9. Machado-Duque ME, García DA, Emura-Velez MH et al (2021) Antibiotic prescriptions for respiratory tract viral infections in the Colombian population. Antibiotics 10:86410.3390/antibiotics10070864 ↗
10. Miyakawa MEF, Casanova NA, Kogut MH (2024) How did antibiotic growth promoters increase growth and feed efficiency in poultry? Poult Sci 103:10327810.1016/j.psj.2023.103278 ↗
11. Van TTH, Yidana Z, Smooker PM, Coloe PJ (2020) Antibiotic use in food animals worldwide, with a focus on Africa: pluses and minuses. J Glob Antimicrob Resist 20:170–17710.1016/j.jgar.2019.07.031 ↗
12. Malik B, Bhattacharyya S (2019) Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep 9:978810.1038/s41598-019-46078-y ↗
13. Pulingam T, Parumasivam T, Gazzali AM et al (2022) Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci 170:10610310.1016/j.ejps.2021.106103 ↗
14. Bernatchez SF (2023) Reducing antimicrobial resistance by practicing better infection prevention and control. Am J Infect Control 51:1063–106610.1016/j.ajic.2023.02.014 ↗
15. Rump B, Timen A, Hulscher M, Verweij M (2020) Infection control measures in times of antimicrobial resistance: a matter of solidarity. Monash Bioeth Rev 38:47–5510.1007/s40592-020-00119-9 ↗
16. Aspenberg M, Maad Sasane S, Nilsson F et al (2023) Hygiene may attenuate selection for antibiotic resistance by changing microbial community structure. Evol Med Public Heal 11:1–710.1093/emph/eoac038 ↗
17. Maillard J-Y, Bloomfield SF, Courvalin P et al (2020) Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: a position paper. Am J Infect Control 48:1090–109910.1016/j.ajic.2020.04.011 ↗
18. Ramay BM, Caudell MA, Cordón-Rosales C et al (2020) Antibiotic use and hygiene interact to influence the distribution of antimicrobial-resistant bacteria in low-income communities in Guatemala. Sci Rep 10:1376710.1038/s41598-020-70741-4 ↗
19. Bassetti S, Tschudin-Sutter S, Egli A, Osthoff M (2022) Optimizing antibiotic therapies to reduce the risk of bacterial resistance. Eur J Intern Med 99:7–1210.1016/j.ejim.2022.01.029 ↗
20. Rahman MM, Alam Tumpa MA, Zehravi M et al (2022) An overview of antimicrobial stewardship optimization: the use of antibiotics in humans and animals to prevent resistance. Antibiotics 11:66710.3390/antibiotics11050667 ↗
21. Geremia N, Giovagnorio F, Colpani A et al (2024) Fluoroquinolones and biofilm: a narrative review. Pharmaceuticals 17:167310.3390/ph17121673 ↗
22. Kwiatkowska B, Maślińska M (2012) Macrolide therapy in chronic inflammatory diseases. Mediators Inflamm 2012:63615710.1155/2012/636157 ↗
23. Pandey N, Cascella M (2023) Beta-lactam antibiotics. In: StatPearls [Internet]. StatPearls Publishing
24. Prescott JF (2013) Beta‐lactam antibiotics: penampenicillins. Antimicrob Ther Vet Med 133–152. https://doi.org/10.1002/9781118675014.ch810.1002/9781118675014.ch8 ↗
25. Tsigara AS, Banti CN, Hatzidimitriou A, Hadjikakou SK (2024) Tetracycline: structural characterization and antimicrobial properties of its water-soluble di-anionic bi-sodium salt. Dalt Trans 53:12080–1208910.1039/D4DT01384K ↗
26. Ahmed S, Sony SA, Chowdhury MB et al (2020) Retention of antibiotic activity against resistant bacteria harbouring aminoglycoside-N-acetyltransferase enzyme by adjuvants: a combination of in-silico and in-vitro study. Sci Rep 10:1938110.1038/s41598-020-76355-0 ↗
27. Hassanein MM (2019) Sulfonamides: far from obsolete. https://doi.org/10.18203/2349-3291.ijcp2019476810.18203/2349-3291.ijcp20194768 ↗
28. Hatfull GF, Dedrick RM, Schooley RT (2022) Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med 73:197–21110.1146/annurev-med-080219-122208 ↗
29. Xuan J, Feng W, Wang J et al (2023a) Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat 68:10095410.1016/j.drup.2023.100954 ↗
30. Ioannou P, Baliou S, Samonis G (2024) Nanotechnology in the diagnosis and treatment of antibiotic-resistant infections. Antibiotics 13:12110.3390/antibiotics13020121 ↗
31. Chakraborty N, Jha D, Roy I et al (2022) Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies. J Nanobiotechnol 20:37510.1186/s12951-022-01573-9 ↗
32. Ramasamy M, Lee J (2016) Recent nanotechnology approaches for prevention and treatment of biofilm-associated infections on medical devices. Biomed Res Int 2016:185124210.1155/2016/1851242 ↗
33. Hajipour MJ, Saei AA, Walker ED et al (2021) Nanotechnology for targeted detection and removal of bacteria: opportunities and challenges. Adv Sci 8:210055610.1002/advs.202100556 ↗
34. Srinivasan S, Elumalai K (2023) The new frontier of drug delivery through nanotechnology. Intell Pharm 1:169–174
35. Bayda S, Adeel M, Tuccinardi T et al (2019) The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine. Molecules 25:11210.3390/molecules25010112 ↗
36. Haghgoo M, Ansari R, Hassanzadeh-Aghdam MK (2020) The effect of nanoparticle conglomeration on the overall conductivity of nanocomposites. Int J Eng Sci 157:10339210.1016/j.ijengsci.2020.103392 ↗
37. Sharma A, Hickman J, Gazit N et al (2018) Nickel nanoparticles set a new record of strength. Nat Commun 9:410210.1038/s41467-018-06575-6 ↗
38. Kolahalam LA, Viswanath IVK, Diwakar BS et al (2019) Review on nanomaterials: Synthesis and applications. Mater Today Proc 18:2182–219010.1016/j.matpr.2019.07.371 ↗
39. Hou JX, Liu SF, Cao BX et al (2022) Designing nanoparticles-strengthened high-entropy alloys with simultaneously enhanced strength-ductility synergy at both room and elevated temperatures. Acta Mater 238:11821610.1016/j.actamat.2022.118216 ↗
40. Suriyanarayanan S, Nicholls IA (2021) Making nanostructured materials from maize, milk and malacostraca. Sci Rep 11:2442010.1038/s41598-021-04001-4 ↗
41. Saeedi M, Eslamifar M, Khezri K, Dizaj SM (2019) Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother 111:666–67510.1016/j.biopha.2018.12.133 ↗
42. Sim S, Wong NK (2021) Nanotechnology and its use in imaging and drug delivery. Biomed reports 14:1–910.3892/br.2021.1418 ↗
43. Adeniji OO, Ojemaye MO, Okoh AI (2022) Antibacterial activity of metallic nanoparticles against multidrug-resistant pathogens isolated from environmental samples: nanoparticles/antibiotic combination therapy and cytotoxicity study. ACS Appl Bio Mater 5:4814–482610.1021/acsabm.2c00527 ↗
44. Di Stefano A (2023) Nanotechnology in targeted drug delivery. Int J Mol Sci 24:819410.3390/ijms24098194 ↗
45. Mubeen B, Ansar AN, Rasool R et al (2021) Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics. Antibiotics 10:147310.3390/antibiotics10121473 ↗
46. Mammari N, Lamouroux E, Boudier A, Duval RE (2022) Current knowledge on the oxidative-stress-mediated antimicrobial properties of metal-based nanoparticles. Microorganisms 10:43710.3390/microorganisms10020437 ↗
47. Mortimer M, Wang Y, Holden PA (2021) Molecular mechanisms of nanomaterial-bacterial interactions revealed by omics—the role of nanomaterial effect level. Front Bioeng Biotechnol 9:68352010.3389/fbioe.2021.683520 ↗
48. Aabed K, Mohammed AE (2021) Synergistic and antagonistic effects of biogenic silver nanoparticles in combination with antibiotics against some pathogenic microbes. Front Bioeng Biotechnol 9:65236210.3389/fbioe.2021.652362 ↗
49. Bagheri Darvish H, Bahrami A, Jafari SM, Williams L (2021) Micro/nanoencapsulation strategy to improve the efficiency of natural antimicrobials against Listeria monocytogenes in food products. Crit Rev Food Sci Nutr 61:1241–125910.1080/10408398.2020.1755950 ↗
50. Siddique MH, Aslam B, Imran M et al (2020) Effect of silver nanoparticles on biofilm formation and EPS production of multidrug-resistant Klebsiella pneumoniae. Biomed Res Int 2020:639816510.1155/2020/6398165 ↗
51. Bruna T, Maldonado-Bravo F, Jara P, Caro N (2021) Silver nanoparticles and their antibacterial applications. Int J Mol Sci 22:720210.3390/ijms22137202 ↗
52. Fadaka AO, Meyer S, Ahmed O et al (2022) Broad spectrum anti-bacterial activity and non-selective toxicity of gum Arabic silver nanoparticles. Int J Mol Sci 23:179910.3390/ijms23031799 ↗
53. Siddique S, Chow JCL (2020) Gold nanoparticles for drug delivery and cancer therapy. Appl Sci 10:382410.3390/app10113824 ↗
54. Huang H, Liu R, Yang J et al (2023) Gold nanoparticles: construction for drug delivery and application in cancer immunotherapy. Pharmaceutics 15:186810.3390/pharmaceutics15071868 ↗
55. Giráldez-Pérez RM, Grueso EM, Carbonero A et al (2023) Synergistic antibacterial effects of amoxicillin and gold nanoparticles: a therapeutic option to combat antibiotic resistance. Antibiotics 12:127510.3390/antibiotics12081275 ↗
56. Bonthula S, Bonthula SR, Pothu R et al (2023) Recent advances in copper-based materials for sustainable environmental applications. Sustain Chem 4:246–27110.3390/suschem4030019 ↗
57. Sengupta I, Bhattacharya P, Talukdar M et al (2019) Bactericidal effect of graphene oxide and reduced graphene oxide: Influence of shape of bacteria. Colloid Interface Sci Commun 28:60–6810.1016/j.colcom.2018.12.001 ↗
58. Ng IMJ, Shamsi S (2022) Graphene oxide (GO): a promising nanomaterial against infectious diseases caused by multidrug-resistant bacteria. Int J Mol Sci 23:909610.3390/ijms23169096 ↗
59. Kang S, Herzberg M, Rodrigues DF, Elimelech M (2008) Antibacterial effects of carbon nanotubes: size does matter! Langmuir 24:6409–641310.1021/la800951v ↗
60. Azizi-Lalabadi M, Hashemi H, Feng J, Jafari SM (2020) Carbon nanomaterials against pathogens; the antimicrobial activity of carbon nanotubes, graphene/graphene oxide, fullerenes, and their nanocomposites. Adv Colloid Interface Sci 284:10225010.1016/j.cis.2020.102250 ↗
61. Spirescu VA, Chircov C, Grumezescu AM, Andronescu E (2021b) Polymeric nanoparticles for antimicrobial therapies: an up-to-date overview. Polymers (Basel) 13:72410.3390/polym13050724 ↗
62. Dop RA, Neill DR, Hasell T (2023) Sulfur-polymer nanoparticles: preparation and antibacterial activity. ACS Appl Mater Interfaces 15:20822–2083210.1021/acsami.3c03826 ↗
63. Wang D-Y, Van der Mei HC, Ren Y et al (2020) Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Front Chem 7:87210.3389/fchem.2019.00872 ↗
64. Scheeder A, Brockhoff M, Ward EN et al (2023) Molecular mechanisms of cationic fusogenic liposome interactions with bacterial envelopes. J Am Chem Soc 145:28240–2825010.1021/jacs.3c11463 ↗
65. Amekyeh H, Billa N (2021) Lyophilized drug-loaded solid lipid nanoparticles formulated with beeswax and theobroma oil. Molecules 26:90810.3390/molecules26040908 ↗
66. Zhao W, Zeng M, Li K et al (2022) Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo. Pharm Biol 60:2300–230710.1080/13880209.2022.2136205 ↗
67. Cao G, Yan J, Ning X et al (2021) Antibacterial and antibiofilm properties of graphene and its derivatives. Colloids Surfaces B Biointerfaces 200:11158810.1016/j.colsurfb.2021.111588 ↗
68. Fernandes M, González-Ballesteros N, da Costa A et al (2023) Antimicrobial and anti-biofilm activity of silver nanoparticles biosynthesized with Cystoseira algae extracts. JBIC J Biol Inorg Chem 28:439–45010.1007/s00775-023-01999-y ↗
69. Li C, Sun F (2021) Graphene-assisted sensor for rapid detection of antibiotic resistance in Escherichia coli. Front Chem 9:69690610.3389/fchem.2021.696906 ↗
70. Kang M-G, Khan F, Tabassum N et al (2023) Inhibition of biofilm and virulence properties of pathogenic bacteria by silver and gold nanoparticles synthesized from Lactiplantibacillus sp. strain C1. ACS Omega 8:9873–988810.1021/acsomega.2c06789 ↗
71. Chehelgerdi M, Chehelgerdi M, Allela OQB et al (2023) Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer 22:16910.1186/s12943-023-01865-0 ↗
72. Khan F, Jeong G-J, Singh P et al (2022) Retrospective analysis of the key molecules involved in the green synthesis of nanoparticles. Nanoscale 14:14824–1485710.1039/D2NR03632K ↗
73. Mondal SK, Chakraborty S, Manna S, Mandal SM (2024) Antimicrobial nanoparticles: current landscape and future challenges. RSC Pharm 1(3):388–40210.1039/D4PM00032C ↗
74. Ealia SAM, Saravanakumar MP (2017) A review on the classification, characterisation, synthesis of nanoparticles and their application. In: IOP conference series: materials science and engineering. IOP Publishing, p 32019
75. Joudeh N, Linke D (2022) Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnol 20:26210.1186/s12951-022-01477-8 ↗
76. Pan K, Zhong Q (2016) Organic nanoparticles in foods: fabrication, characterization, and utilization. Annu Rev Food Sci Technol 7:245–26610.1146/annurev-food-041715-033215 ↗
77. Spirescu VA, Chircov C, Grumezescu AM et al (2021a) Inorganic nanoparticles and composite films for antimicrobial therapies. Int J Mol Sci 22:459510.3390/ijms22094595 ↗
78. Chandrakala V, Aruna V, Angajala G (2022) Review on metal nanoparticles as nanocarriers: Current challenges and perspectives in drug delivery systems. Emergent Mater 5:1593–161510.1007/s42247-021-00335-x ↗
79. Rao KJ, Paria S (2015) Aegle marmelos leaf extract and plant surfactants mediated green synthesis of Au and Ag nanoparticles by optimizing process parameters using Taguchi method. ACS Sustain Chem Eng 3:483–49110.1021/acssuschemeng.5b00022 ↗
80. Marc Najjar MD, Ross M, Srivastava A et al (2019) 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part. J Immunother Cancer 7:P110.1186/s40425-018-0484-x ↗
81. Zhang S, Lin L, Huang X et al (2022) Antimicrobial properties of metal nanoparticles and their oxide materials and their applications in oral biology. J Nanomater 2022:206326510.1155/2022/2063265 ↗
82. Díez-Pascual AM (2021) Carbon-based nanomaterials. Int J Mol Sci 22:772610.3390/ijms22147726 ↗
83. Maiti D, Tong X, Mou X, Yang K (2019) Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol 9:140110.3389/fphar.2018.01401 ↗
84. Díez-Pascual AM (2020) Antibacterial action of nanoparticle loaded nanocomposites based on graphene and its derivatives: a mini-review. Int J Mol Sci 21:356310.3390/ijms21103563 ↗
85. Chang H, Wu H (2013) Graphene-based nanomaterials: synthesis, properties, and optical and optoelectronic applications. Adv Funct Mater 23:1984–199710.1002/adfm.201202460 ↗
86. Abo-Neima SE, Motaweh HA, Elsehly EM (2020) Antimicrobial activity of functionalised carbon nanotubes against pathogenic microorganisms. IET Nanobiotechnol 14:457–46410.1049/iet-nbt.2019.0342 ↗
87. Maghimaa M, Sagadevan S, Boojhana E, Fatimah I, Lett JA, Moharana S et al (2024) Enhancing biocompatibility and functionality: carbon nanotube-polymer nanocomposites for improved biomedical applications. J Drug Deliv Sci Technol 10595810.1016/j.jddst.2024.105958 ↗
88. Gosecka M, Gosecki M (2021) Antimicrobial polymer-based hydrogels for the intravaginal therapies—engineering considerations. Pharmaceutics 13:139310.3390/pharmaceutics13091393 ↗
89. Wang Y, Sun H (2021) Polymeric nanomaterials for efficient delivery of antimicrobial agents. Pharmaceutics 13:210810.3390/pharmaceutics13122108 ↗
90. Smola-Dmochowska A, Lewicka K, Macyk A et al (2023) Biodegradable polymers and polymer composites with antibacterial properties. Int J Mol Sci 24:747310.3390/ijms24087473 ↗
91. Adhikari C (2021) Polymer nanoparticles-preparations, applications and future insights: a concise review. Polym Technol Mater 60:1996–2024
92. Singh RP, Ramarao P (2013) Accumulated polymer degradation products as effector molecules in cytotoxicity of polymeric nanoparticles. Toxicol Sci 136:131–14310.1093/toxsci/kft179 ↗
93. Saini RK, Bagri LP, Bajpai AK, Mishra A (2018) Responsive polymer nanoparticles for drug delivery applications. In: Stimuli responsive polymeric nanocarriers for drug delivery applications, Volume 1. Elsevier, pp 289–32010.1016/B978-0-08-101997-9.00015-1 ↗
94. Armentano I, Arciola CR, Fortunati E et al (2014) The interaction of bacteria with engineered nanostructured polymeric materials: a review. Sci World J 2014:41042310.1155/2014/410423 ↗
95. Dararatana N, Seidi F, Hamel J, Crespy D (2020) Controlling release kinetics of pH-responsive polymer nanoparticles. Polym Chem 11:1752–176210.1039/C9PY01946D ↗
96. Sayed FA-Z, Eissa NG, Shen Y et al (2022) Morphologic design of nanostructures for enhanced antimicrobial activity. J Nanobiotechnology 20:53610.1186/s12951-022-01733-x ↗
97. Lee ALZ, Ng VWL, Wang W et al (2013) Block copolymer mixtures as antimicrobial hydrogels for biofilm eradication. Biomaterials 34:10278–1028610.1016/j.biomaterials.2013.09.029 ↗
98. Qiu Y, Xu D, Sui G et al (2020) Gentamicin decorated phosphatidylcholine-chitosan nanoparticles against biofilms and intracellular bacteria. Int J Biol Macromol 156:640–64710.1016/j.ijbiomac.2020.04.090 ↗
99. Plaza-Oliver M, Santander-Ortega MJ, Lozano MV (2021) Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res 11:471–49710.1007/s13346-021-00908-7 ↗
100. Sonju JJ, Dahal A, Jois SD (2022) Liposome nanocarriers for peptide drug delivery. In: Peptide therapeutics: fundamentals of design, development, and delivery. Springer, pp 203–23510.1007/978-3-031-04544-8_6 ↗